The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to ensure durable glycemic control and prevent long-term complications. In…
New Delhi: The Delhi Urban Arts Commission (DUAC) has refused to issue a completion no objection certificate (NOC) for the new super speciality block at Ram Manohar Lohia (RML) hospital,…
Vijayawada: Healthcare services under the Dr. NTR Vaidya Seva scheme in Andhra Pradesh are set to resume after a six-day suspension, following a strike by private network hospitals demanding the…
A new study published in the Journal of the American Medical Association found fewer than 25% (21.2%) of patients—particularly veterans—with heart failure with reduced ejection fraction (HFrEF) to achieve quadruple…
A new study published in the journal of Bone that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modest reduction in femur fracture risk. However, because…
USA: Adults with type 2 diabetes who begin treatment with certain glucose-lowering medications may face differing risks for developing depression, a large real-world study published in Diabetes, Obesity and Metabolism…
Ubl led PhRMA through the pandemic and a slew of efforts to rein in drug prices from Democrats and Republicans.
Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The recent study published in…
Hyderabad: Drugmaker Dr. Reddy's Laboratories Limited has entered into an agreement to sell its entire shareholding in its wholly owned subsidiary, Svaas Wellness Limited, for a consideration of Rs 2.23…
New Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in multiple strengths, the…